Olanzapine
- 225 trials, 117 with no results posted
- 61 of 225 trials sponsored by its developers
- Humans1
Trial sponsors
Company43 trialsPhase 412,342 people
Company5 trialsPhase 4306 people
Company2 trialsPhase 418,257 people
Company2 trialsPhase 4580 people
Company2 trialsPhase 4544 people
Company1 trialPhase 464 people
Company1 trialPhase 459 people
Company1 trialPhase 413 people
Latest
2 in 12 monthsJournal of the American Heart Association
Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
Cohort study of 91,774 peoplePopulations